Delta Asset Management’s West Pharmaceutical WST Stock Holding History

Delta Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13	Closed	-$1K	–	692
2018 Q2	$1K	Hold	13	–	–	﹤0.01%	652
2018 Q1	$1K	Hold	13	–	–	﹤0.01%	659
2017 Q4	$1K	Hold	13	–	–	﹤0.01%	676
2017 Q3	$1K	Buy	+13	New	+$1.18K	﹤0.01%	657
2016 Q1	–	Sell	-36	Closed	-$2K	–	624
2015 Q4	$2K	Hold	36	–	–	﹤0.01%	585
2015 Q3	$2K	Buy	+36	New	+$2.1K	﹤0.01%	588

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Delta Asset Management's WST Position: Q3 2018 in Review

Delta Asset Management sold out of West Pharmaceutical (WST) in Q3 2018, closing a stake of 13 shares — an estimated $1K sold.

Delta Asset Management first reported a position in WST in Q3 2015 and held it in 6 quarters. The position peaked at $2K in Q4 2015. 355 funds tracked by Wall St. Rank hold WST as of Q3 2018.

Delta Asset Management reported no remaining West Pharmaceutical position as of Q3 2018 after selling out during the quarter.
Delta Asset Management sold 13 West Pharmaceutical shares in Q3 2018, an estimated $1K.
Delta Asset Management first reported a position in West Pharmaceutical in Q3 2015 and held it in 6 quarters.
Delta Asset Management's West Pharmaceutical position peaked at $2K in Q4 2015.
355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2018.

Based on Delta Asset Management's 13F filing for Q3 2018, filed 22 Oct 2018.